News | February 24, 2012

CardioInsight Completes First Commercial Product Installation of its ECVUE Cardiac Mapping System

The ECVUE System provides detailed images of the heart

February 24, 2012 — CardioInsight Technologies Inc. announced that it has successfully completed the European commercial introduction of its ECVUE system to aid in the diagnosis of cardiac arrhythmias. St. Mary's Hospital in London became the company's first commercial customer.  Doctors Prapa Kanagaratnam, Wyn Davies, Nick Peters, David Lefroy, Boon Lim and Shahnaz Jamil-Copley demonstrated the system's effectiveness in a day-to-day clinical setting, completing five clinical cases during its first week of clinical use.

"We are excited to be CardioInsight's first commercial partner and I was very impressed with the ECVUE system's unique ability to display global cardiac activation without the need for an invasive study," said Dr. Prapa Kanagaratnam, the clinical lead for cardiac electrophysiology at St. Mary's Hospital, Imperial College Healthcare. "I think there is a real potential that this could be a disruptive technology that produces a paradigm shift in our approach to managing patients with cardiac arrhythmias."

St. Mary's Hospital has long been recognized as a leading institution in the study of cardiac electrophysiology, dating back to the first systematic clinical use of electrical recordings of the heart's activity in the early 1900's.  Dr. Davies and his team later became a pioneering center for catheter-based 3D mapping.

"We are proud to have the opportunity to work with the world-class team from St. Mary's Hospital as we look to demonstrate the clinical impact of the ECVUE system," said Steve Arless, CEO of CardioInsight.  "I believe their commitment to help pioneer our non-invasive mapping system is a testament to the ECVUE system's clinical potential, and we look forward to further demonstrating this potential under their guidance."

The commercial installation at St. Mary's Hospital is the first of a focused commercial introduction of the ECVUE system in Europe to demonstrate the unique ability to simplify cardiac mapping procedures, reduce procedure time, and expand the use of mapping to new applications.

For more information:

Related Content

Acutus AcQMap Imaging System Helps Eliminate Arrhythmia With Single Ablation
News | EP Mapping and Imaging Systems | January 28, 2019
Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap advanced cardiac...
First Carto Vizigo Bi-Directional Guiding Sheath Employed on West Coast
News | EP Mapping and Imaging Systems | October 29, 2018
October 29, 2018 — Good Samaritan Hospital recently became the first hospital on the West Coast to utilize the Carto
BioSig Technologies Announces FDA 510(k) Clearance for Pure EP System
Technology | EP Mapping and Imaging Systems | August 14, 2018
BioSig Technologies Inc. announced that the company received 510(k) clearance for its first product, Pure EP System,...
Volta Medical Brings Artificial Intelligence to Cardiac Electrophysiology

Image courtesy of Intermountain Medical Center Heart Institute

News | EP Mapping and Imaging Systems | June 12, 2018
Volta Medical, out of Marseille, France, has developed the first artificial intelligence (AI) software to guide...
APN Health Releases Navik 3D Cardiac Mapping System
Technology | EP Mapping and Imaging Systems | May 03, 2018
May 3, 2018 — APN Health LLC announced its Navik 3D...
Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled
Technology | EP Mapping and Imaging Systems | January 19, 2018
Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping Catheter, Sensor Enabled, a...
Videos | EP Mapping and Imaging Systems | October 24, 2017
This video, provided by Acutus Medical, demonstrates a patient case showing the use of the AcQMap high-resolution ele
Acutus Medical Receives FDA Clearance for AcQMap Cardiac Mapping Technology
Technology | EP Mapping and Imaging Systems | October 24, 2017
Acutus Medical announced that the U.S. Food and Drug Administration (FDA) has cleared the AcQMap High Resolution...
Acutus Medical Announces Completion of Enrollment for UNCOVER AF Study
News | EP Mapping and Imaging Systems | May 02, 2017
Acutus Medical recently announced that enrollment has been completed in its pivotal Utilizing Novel Dipole Density...
Overlay Init